Elanco Animal Health (NYSE: ELAN) director buys 10,000 shares at $23.69
Rhea-AI Filing Summary
Elanco Animal Health Inc director Paul Herendeen reported an open-market purchase of 10,000 shares of Common Stock on August 7, 2026 at $23.685 per share. Following this transaction, his reported direct ownership increased to 111,687 common shares of Elanco Animal Health Inc.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 10,000 shares
Net Buy
1 txn
Insider
Herendeen Paul
Role
Director
Bought
10,000 shs ($237K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 10,000 | $23.685 | $237K |
Holdings After Transaction:
Common Stock — 111,687 shares (Direct)
Key Figures
Shares purchased: 10,000 shares
Purchase price per share: $23.685 per share
Shares owned after transaction: 111,687 shares
3 metrics
Shares purchased
10,000 shares
Common Stock acquired on August 7, 2026
Purchase price per share
$23.685 per share
Price paid for Common Stock on August 7, 2026
Shares owned after transaction
111,687 shares
Direct holdings following the reported purchase
Key Terms
Common Stock, open market or private transaction, Form 4
3 terms
Common Stock financial
"security_title": "Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
open market or private transaction financial
"transaction_code_description": "Purchase in open market or private transaction"
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did ELAN director Paul Herendeen report?
Paul Herendeen reported purchasing 10,000 shares of Elanco Animal Health Inc common stock on August 7, 2026 at $23.685 per share in an open-market or private transaction.
Was the ELAN insider trade by Paul Herendeen a purchase or sale?
The Form 4 reports a purchase of Elanco Animal Health Inc common stock by Paul Herendeen, coded as transaction type P, which represents a purchase in an open market or private transaction.
Was Paul Herendeen’s ELAN stock purchase under a Rule 10b5-1 trading plan?
The Form 4’s Rule 10b5-1 checkbox is not marked as affirmative, indicating the reported 10,000-share purchase was not identified in the form as being made pursuant to a Rule 10b5-1 trading plan.